Automated Breast Ultrasound Systems (ABUS) Market to Grow Globally

The high prevalence and incidence rate of breast cancer is a primary factor driving the growth of the market for automated breast ultrasonography systems. According to the American Cancer Society, there will be 246,660 new cases of breast cancer recorded in the United States year 2016. Furthermore, the risk of breast cancer rises with age. The WHO's initiatives, in partnership with national governments, to encourage early detection, diagnosis, and treatment are driving up demand for ABUS for breast screening. However, the high expenses of installation and human training are limiting industry expansion. To improve their market presence, organizations are using measures such as delivering FDA-approved on-site training, engaging in strategic alliances, and incorporating innovations in their current portfolio.

The use of traditional handheld ultrasound equipment (HHUS) is time-intensive and necessitates technical expertise in picture analysis. The introduction of automated breast ultrasound systems (ABUS) has aided in the resolution of this problem. The Food and Drug Administration (FDA) of the United States authorized ABUS in 2015 for additional screening of women with thick breasts. It is also being used in preoperative examination to detect the existence and quantity of cancer tissues before surgery. As a result, it is critical for ultrasound system manufacturers to actively watch the numerous trends in this highly profitable industry and align their company strategies accordingly to benefit from these possibilities.

This study categorizes the market for automated breast ultrasound systems based on product type, application, and end-use. The market has been divided into prone-type and supine-type automated breast ultrasound systems based on product type. The market has been divided into two categories based on application: screening and pre-operative assessment. The ABUS market is divided into three end-user segments: hospitals, ambulatory surgical units, and diagnostic centers. The ABUS market is also examined in terms of main geographies, including North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.